Bacterial load in lung and spleen of binge-drinking mice intranasally infected with decreasing doses of <i>B</i>. <i>thailandensis</i>. by Victor M. Jimenez Jr. (8107853)

Genes whose expression was decreased by 1 mM ouabain by more than 2-fold. by Larisa V. Smolyaninova (3600053)

Survivability is decreased in zebrafish embryos following exogenous treatment with an amino-terminal fragment of nApoE4_1-151. by Madyson M. McCarthy (9238322)

Graphical visualization of the Taqman fold changes. by Bettina Bohusné Barta (12536846)

<i>Ubr5</i>^<i>mt</i> synovium exhibits markers of increased canonical and decreased non-canonical HH signalling. by David Mellis (2833469)

Relative fold change (relative to untreated control cells) of the EGFR gene among LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

Subjects:

Upregulated genes in the thalamus of the mouse exposed sound stress (fold change > 1.5). by Satoka Kasai (3861115)

K-fold cross validation accuracy of different models. by Shayla Naznin (13014015)

Subjects:

Genes whose expression was decreased by 100 nM ouabain by more than 1.3-fold. by Larisa V. Smolyaninova (3600053)

Voluntary mobility and distancing measures decrease the spread of SARS-CoV2 in Mexico City by Guillermo de Anda‐Jáuregui (9183620)

Endoscopic injection into the vocal fold muscle. by Ikuo Mikoshiba (9312007)

Subjects:

Folding and stability of GDAP1 as affected by CMT mutations. by Aleksi Sutinen (10039145)

Data_Sheet_2_Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma.docx by Vanessa M. Beutgen (6432671)

Data_Sheet_1_Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma.docx by Vanessa M. Beutgen (6432671)

ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)

Validation accuracy of our custom CNN model with the directional filters over 5 folds. by Salih Furkan Atici (12988243)

Marker genes for the non-immune clusters. by Emilie Pollenus (10147748)

Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

“…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC_{(tofacitinib, 0–∞)} and a 9.61-fold increase of colonic AUC_{(tofacitinib, 0–12h)}, compared with tofacitinib at a molar equivalent oral dose. …”

Fig 5 - by Lingru Ruan (18995544)

Relative fold change (relative to untreated control cells) of the <i>HER-2</i> gene among LS174T and IEC-18 cells. by Asadollahi Parisa (8837432)

Subjects: